Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is $950.1, with a 24-hour trading volume of $2.67B. The asset's market cap is $847.24B, after moving 2.61% in the last day.
Tokenized Eli Lilly And Co is trading at $1,016.14, with a tokenized market cap of $5.7M and a 24-hour trading volume of $3.32M. The tokenized asset has moved 2.53% in the past 24 hours.